Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
5,467,856
-
Shares change
-
-248,845
-
Total reported value, excl. options
-
$36,368,000
-
Value change
-
-$1,516,917
-
Number of buys
-
16
-
Number of sells
-
-18
-
Price
-
$6.66
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q1 2015
48 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q1 2015.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,467,856 shares
of 14,965,850 outstanding shares and own 36.54% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (1,907,242 shares), DIMENSIONAL FUND ADVISORS LP (847,135 shares), MILLENNIUM MANAGEMENT LLC (613,430 shares), BlackRock Institutional Trust Company, N.A. (449,408 shares), VANGUARD GROUP INC (285,546 shares), NEW YORK STATE COMMON RETIREMENT FUND (221,407 shares), RENAISSANCE TECHNOLOGIES LLC (170,188 shares), Invesco Ltd. (88,640 shares), BARD ASSOCIATES INC (86,940 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (84,000 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.